Shu Leong Ho

1.2k total citations
28 papers, 765 citations indexed

About

Shu Leong Ho is a scholar working on Neurology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Shu Leong Ho has authored 28 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Neurology, 5 papers in Pathology and Forensic Medicine and 4 papers in Epidemiology. Recurrent topics in Shu Leong Ho's work include Peripheral Neuropathies and Disorders (6 papers), Parkinson's Disease Mechanisms and Treatments (5 papers) and Multiple Sclerosis Research Studies (4 papers). Shu Leong Ho is often cited by papers focused on Peripheral Neuropathies and Disorders (6 papers), Parkinson's Disease Mechanisms and Treatments (5 papers) and Multiple Sclerosis Research Studies (4 papers). Shu Leong Ho collaborates with scholars based in Hong Kong, China and United Kingdom. Shu Leong Ho's co-authors include Philip Wing‐Lok Ho, Raymond Tak Fai Cheung, Kui Kai Lau, Henry Ka‐Fung Mak, David Sai Wah Ho, Michela Simoni, Linxin Li, Wilhelm Küker, Peter M. Rothwell and Ursula G. Schulz and has published in prestigious journals such as Nature Communications, PLoS ONE and Neurology.

In The Last Decade

Shu Leong Ho

27 papers receiving 748 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shu Leong Ho Hong Kong 16 430 177 160 125 114 28 765
Jin Myoung Seok South Korea 15 281 0.7× 332 1.9× 220 1.4× 208 1.7× 117 1.0× 57 811
Tadayuki Maehara Japan 19 208 0.5× 336 1.9× 159 1.0× 107 0.9× 72 0.6× 57 1.1k
Peter Lüdemann Germany 18 255 0.6× 121 0.7× 149 0.9× 52 0.4× 53 0.5× 36 832
Yinn Cher Ooi United States 14 253 0.6× 94 0.5× 120 0.8× 56 0.4× 119 1.0× 32 735
Janja Pretnar Oblak Slovenia 17 345 0.8× 262 1.5× 245 1.5× 44 0.4× 257 2.3× 66 915
R. Monforte Spain 11 281 0.7× 148 0.8× 54 0.3× 94 0.8× 60 0.5× 31 676
A. De Kersaint-Gilly France 12 312 0.7× 162 0.9× 327 2.0× 35 0.3× 162 1.4× 51 861
Yen-Chu Huang Taiwan 18 250 0.6× 292 1.6× 165 1.0× 31 0.2× 91 0.8× 66 764
Manuel Gómez‐Choco Spain 15 296 0.7× 461 2.6× 120 0.8× 110 0.9× 88 0.8× 47 1.1k
Stephan Schreiber Germany 16 555 1.3× 143 0.8× 108 0.7× 40 0.3× 65 0.6× 26 755

Countries citing papers authored by Shu Leong Ho

Since Specialization
Citations

This map shows the geographic impact of Shu Leong Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Leong Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Leong Ho more than expected).

Fields of papers citing papers by Shu Leong Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu Leong Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Leong Ho. The network helps show where Shu Leong Ho may publish in the future.

Co-authorship network of co-authors of Shu Leong Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Shu Leong Ho. A scholar is included among the top collaborators of Shu Leong Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Leong Ho. Shu Leong Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
ffytche, Dominic, Simon J.G. Lewis, Phil Hyu Lee, et al.. (2022). Mapping brain structural differences and neuroreceptor correlates in Parkinson’s disease visual hallucinations. Nature Communications. 13(1). 519–519. 22 indexed citations
2.
3.
Li, Mulin Jun, Jiaen Deng, Panwen Wang, et al.. (2015). wKGGSeq: A Comprehensive Strategy-Based and Disease-Targeted Online Framework to Facilitate Exome Sequencing Studies of Inherited Disorders. Human Mutation. 36(5). 496–503. 8 indexed citations
4.
Li, Miaoxin, et al.. (2014). PMCA4 (ATP2B4) Mutation in Familial Spastic Paraplegia. PLoS ONE. 9(8). e104790–e104790. 27 indexed citations
5.
6.
Wong, Yuen Kwun, et al.. (2013). Prognosis after Status Epilepticus (P07.175). Neurology. 80(7_supplement). 1 indexed citations
7.
Cheung, Raymond Tak Fai, et al.. (2012). Guillain–Barré syndrome associated with acute hepatitis E infection. Journal of Clinical Neuroscience. 19(4). 607–608. 28 indexed citations
8.
Turan, Nil, et al.. (2012). Detection of endocrine disruptors – from simple assays to whole genome scanning. International Journal of Andrology. 35(3). 407–414. 8 indexed citations
9.
Chan, Koon Ho, Philip Wing‐Lok Ho, Jessica Wing-Man Ho, et al.. (2011). Clinical outcome of relapsing remitting multiple sclerosis among Hong Kong Chinese. Clinical Neurology and Neurosurgery. 113(8). 617–622. 15 indexed citations
10.
Tzeng, Gwo‐Hshiung, et al.. (2010). Configuring the next generation handset by using an emotional design based MCDM framework. Portland International Conference on Management of Engineering and Technology. 1–10. 1 indexed citations
11.
Chan, K. H., et al.. (2007). Nonthymoma early-onset- and late-onset-generalized myasthenia gravis—A retrospective hospital-based study. Clinical Neurology and Neurosurgery. 109(8). 686–691. 10 indexed citations
12.
Ho, Philip Wing‐Lok, et al.. (2006). Idiopathic inflammatory demyelinating disorders after acute transverse myelitis. European Journal of Neurology. 13(8). 862–868. 21 indexed citations
13.
Mak, Winifred, et al.. (2005). Cerebrospinal fluid to serum glucose ratio in non-hypoglycorrhachic neurological conditions.. PubMed. 11(6). 457–62. 8 indexed citations
14.
Ho, Philip Wing‐Lok, et al.. (2004). Idiopathic severe recurrent transverse myelitis: a restricted variant of neuromyelitis optica. Clinical Neurology and Neurosurgery. 107(2). 132–135. 22 indexed citations
15.
Ho, David Sai Wah, et al.. (2001). Intracarotid Abciximab Injection to Abort Impending Ischemic Stroke during Carotid Angioplasty. Cerebrovascular Diseases. 11(4). 300–304. 17 indexed citations
16.
Jiang, Huiping, et al.. (2001). The use of estrogen in the treatment of Parkinson's disease. Parkinsonism & Related Disorders. 8(2). 133–137. 10 indexed citations
17.
Wong, Patrick C. M., et al.. (2001). Perception of Cantonese Parkinsonian speech. The Journal of the Acoustical Society of America. 109(5_Supplement). 2314–2314. 1 indexed citations
18.
Ho, David Sai Wah, et al.. (2000). Epileptic Seizures Attributed to Cerebral Hyperperfusion after Percutaneous Transluminal Angioplasty and Stenting of the Internal Carotid Artery. Cerebrovascular Diseases. 10(5). 374–379. 44 indexed citations
19.
Mak, Joyce Wing Yan, et al.. (1999). Cost of epilepsy in Hong Kong: experience from a regional hospital. Seizure. 8(8). 456–464. 24 indexed citations
20.
Ho, David Sai Wah, et al.. (1998). Prevalence of Extracranial Carotid and Vertebral Artery Disease in Chinese Patients With Coronary Artery Disease. Stroke. 29(3). 631–634. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jin Myoung Seok Breakdown of academic impact, for papers by Tadayuki Maehara Breakdown of academic impact, for papers by Peter Lüdemann Breakdown of academic impact, for papers by Yinn Cher Ooi Breakdown of academic impact, for papers by Janja Pretnar Oblak Breakdown of academic impact, for papers by R. Monforte Breakdown of academic impact, for papers by A. De Kersaint-Gilly Breakdown of academic impact, for papers by Yen-Chu Huang Breakdown of academic impact, for papers by Manuel Gómez‐Choco Breakdown of academic impact, for papers by Stephan Schreiber
Rankless by CCL
2026